Leptomeningeal carcinomatosis (LMC) is an uncommon and devastating late complication of metastatic malignancy that carries a poor prognosis, typically faring worse when secondary to solid tumors. Diagnosis of LMC can be challenging, especially if the underlying cancer is undiagnosed, as presenting symptoms can be nonspecific or involve focal deficits such as cranial nerve palsies. Typically, LMC can be recognized due to new central neurological findings with concomitant peripheral nerve involvement, but there has not been a case of LMC with isolated peripheral nerve findings to our knowledge. In this report, we present a case of LMC secondary to metastatic gastric adenocarcinoma in a patient whose only manifestation was cranial nerve palsie...
Primary leptomeningeal lymphoma (PLML) is a rare entity, representing 7 % of all cases of primary ce...
BACKGROUND: Leptomeningeal carcinomatosis (LC) is a rare metastatic complication of solid tumours. I...
Leptomeningeal disease (LMD) occurs in less than 5% of breast cancer patients. Rarely, patients pres...
Leptomeningeal carcinomatosis (LMC) is defined as the diffuse infiltration of malignant cells th...
Leptomeningeal carcinomatosis (LMC) is rare metastatic form of gastric cancer. Most cases are diagno...
Leptomeningeal disease, also known as leptomeningeal carcinomatosis, occurs when cancer metastasizes...
WOS: 000292752300014PubMed ID: 21796558Gastric cancer is the third most common malignancy among gast...
Leptomeningeal carcinomatosis is a rare complication of metastatic systemic malignancy, with lung ca...
Leptomeningeal carcinomatosis (LMC) is a diffuse or multifocal malignant infiltration of the pia mat...
Leptomeningeal disease (LMD) can occur in a small percentage of patients with active metastatic canc...
Introduction. Leptomeningeal carcinomatosis occurs in about 5% of cancer patients. Ocular involvemen...
We present a 68-year-old male with leptomeningeal carcinomatosis (LC) from gastroesophageal junction...
Leptomeningeal carcinomatosis (LC) is rare complication of cancer involving spread of cancer cells i...
Purpose: Leptomeningeal carcinomatosis occurs in about 5% of patients with solid tumor and is being ...
BACKGROUND: Leptomeningeal carcinomatosis is a rare complication of solid tumors, e. g., breast, lun...
Primary leptomeningeal lymphoma (PLML) is a rare entity, representing 7 % of all cases of primary ce...
BACKGROUND: Leptomeningeal carcinomatosis (LC) is a rare metastatic complication of solid tumours. I...
Leptomeningeal disease (LMD) occurs in less than 5% of breast cancer patients. Rarely, patients pres...
Leptomeningeal carcinomatosis (LMC) is defined as the diffuse infiltration of malignant cells th...
Leptomeningeal carcinomatosis (LMC) is rare metastatic form of gastric cancer. Most cases are diagno...
Leptomeningeal disease, also known as leptomeningeal carcinomatosis, occurs when cancer metastasizes...
WOS: 000292752300014PubMed ID: 21796558Gastric cancer is the third most common malignancy among gast...
Leptomeningeal carcinomatosis is a rare complication of metastatic systemic malignancy, with lung ca...
Leptomeningeal carcinomatosis (LMC) is a diffuse or multifocal malignant infiltration of the pia mat...
Leptomeningeal disease (LMD) can occur in a small percentage of patients with active metastatic canc...
Introduction. Leptomeningeal carcinomatosis occurs in about 5% of cancer patients. Ocular involvemen...
We present a 68-year-old male with leptomeningeal carcinomatosis (LC) from gastroesophageal junction...
Leptomeningeal carcinomatosis (LC) is rare complication of cancer involving spread of cancer cells i...
Purpose: Leptomeningeal carcinomatosis occurs in about 5% of patients with solid tumor and is being ...
BACKGROUND: Leptomeningeal carcinomatosis is a rare complication of solid tumors, e. g., breast, lun...
Primary leptomeningeal lymphoma (PLML) is a rare entity, representing 7 % of all cases of primary ce...
BACKGROUND: Leptomeningeal carcinomatosis (LC) is a rare metastatic complication of solid tumours. I...
Leptomeningeal disease (LMD) occurs in less than 5% of breast cancer patients. Rarely, patients pres...